We are live on ! Find out more
BRLI

BIO-REFERENCE LABS INC-NEW-
BRLI

Delisted

BRLI was delisted on the 19th of August, 2015.

168 hedge funds and large institutions have $673M invested in BIO-REFERENCE LABS INC-NEW- in 2014 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 55 increasing their positions, 65 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 168168 (0)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

0% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 15

12% less capital invested

Capital invested by funds: $760M → $673M (-$87.6M)

15% less repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 65

61% less call options, than puts

Call options by funds: $5.91M | Put options by funds: $15.3M

Holders
168
Holders Change
Holders Change %
0%
% of All Funds
4.87%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.12%
New
15
Increased
55
Reduced
65
Closed
15
Calls
$5.91M
Puts
$15.3M
Net Calls
-$9.42M
Net Calls Change
-$6.02M
Name Holding Trade Value Shares
Change
Change in
Stake
M&T Bank
101
M&T Bank
New York
$443K +$481K +15,810 New
BG
102
BlackRock Group
United Kingdom
$435K -$19.3K -633 -4%
RFC
103
Russell Frank Company
Washington
$435K +$125K +4,107 +36%
Envestnet Asset Management
104
Envestnet Asset Management
Illinois
$413K -$364K -11,952 -45%
BA
105
BlackRock Advisors
Delaware
$398K -$6.33K -208 -1%
EAM
106
EULAV Asset Management
Florida
$398K
ZCM
107
Zebra Capital Management
Connecticut
$396K +$13.9K +456 +3%
VOYA Investment Management
108
VOYA Investment Management
Georgia
$373K
CIA
109
Choate Investment Advisors
Massachusetts
$365K
RAM
110
Redmond Asset Management
Virginia
$360K -$380K -12,481 -49%
Natixis Advisors
111
Natixis Advisors
Massachusetts
$357K -$48.8K -1,603 -11%
OA
112
OFI Advisors
Pennsylvania
$345K +$19.5K +641 +5%
CAM
113
Capstone Asset Management
Texas
$336K -$4.57K -150 -1%
BUB
114
BBVA USA Bancshares
Texas
$333K -$18.8K -618 -5%
GHAM
115
Gilman Hill Asset Management
Connecticut
$330K +$21.3K +700 +6%
B
116
Baird
Wisconsin
$323K -$240K -7,891 -41%
LSERS
117
Louisiana State Employees Retirement System
Louisiana
$320K -$3.04K -100 -0.9%
WSFS
118
Wilmington Savings Fund Society
Delaware
$301K -$110K -3,600 -25%
ProShare Advisors
119
ProShare Advisors
Maryland
$291K -$78K -2,562 -20%
HEIP
120
Hudson Edge Investment Partners
New Jersey
$291K -$2.74K -90 -0.9%
GC
121
Guggenheim Capital
Illinois
$285K -$2.92K -96 -0.9%
ETM
122
Euclidean Technologies Management
Washington
$281K
TRSOTSOK
123
Teachers Retirement System of the State of Kentucky
Kentucky
$275K
Thrivent Financial for Lutherans
124
Thrivent Financial for Lutherans
Minnesota
$251K -$1.52K -50 -0.6%
Allianz Asset Management
125
Allianz Asset Management
Germany
$246K -$116K -3,800 -30%

BRLI Hedge Fund Activity: Q3 2014 in Review

168 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in BIO-REFERENCE LABS INC-NEW- (BRLI) for Q3 2014, worth a combined $673M — down 12% from $760M a quarter earlier.

Fund positioning in BRLI was balanced in Q3 2014: 15 funds opened new positions, 15 closed out, 55 added to existing stakes and 65 trimmed.

The largest buyer was Northern Trust, adding an estimated $6.26M. The largest seller was Epoch Investment Partners, cutting an estimated $10.8M.

  • 168 institutional investors held BIO-REFERENCE LABS INC-NEW- (BRLI) as of Q3 2014, unchanged from Q2 2014.
  • Funds reported $673M of BIO-REFERENCE LABS INC-NEW- stock for Q3 2014, down 12% quarter-over-quarter.
  • 15 funds opened new BIO-REFERENCE LABS INC-NEW- positions in Q3 2014 and 15 closed out, a net change of 0 holders.
  • The largest BIO-REFERENCE LABS INC-NEW- buyer in Q3 2014 was Northern Trust, an estimated $6.26M added.
  • The largest BIO-REFERENCE LABS INC-NEW- seller in Q3 2014 was Epoch Investment Partners, an estimated $10.8M sold.

Based on aggregated 13F filings for Q3 2014.